Endo Health Solutions
Generic pharmaceutical manufacturer Actavis (NYSE: ACT) made headlines after confirming that it has entered into early stage discussions with Ireland-based pharmaceutical firm Warner Chilcott (NASDAQ: WCRX) over a possible merger of the two companies. It is worth noting that Actavis is a generics giant, but the latest target of this acquisition-hungry machine is a specialty player.
Actavis was known as Watson Pharmaceuticals until October last year and has made a more »
Editor's Note: The initial version contained inaccuracies, this version has been corrected.
Endo Health Solutions (NASDAQ: ENDP), a diversified healthcare company specializing in pain medication, has been sending out mixed signals recently. News of increased federal scrutiny of painkillers, exacerbated by key patent expirations, have caused shares to slide 16% over the past six months. What does all this noise mean for the future of Endo, and how should more »
Warner Chilcott (NASDAQ: WCRX) is a specialty pharmaceutical company based in Dublin, Ireland. Two positive news items came out for WCRX recently. It is in the mix to acquire Endo Health Solutions (NASDAQ: ENDP), and it recently announced FDA approval of a product that should extend the lifespan of its most important drug franchise. Also, the shares appear relatively inexpensive.
Warner Chilcott’s products focus on women’s healthcare, gastroenterology more »
Small-cap and mid-cap stocks don’t get as much attention from bankers, third-party analysts, and the media, which often leaves them less efficiently priced than large- and mega-caps. Hedge funds sometimes take advantage of this by dedicating their research teams to work on these lower valuation stocks as well, and so often earn substantial alpha from their investments. Retail investors can use smaller-cap stocks that hedge funds reported owning as more »
Visium Asset Management was founded by Jacob Gottlieb in 2005. Gottlieb graduated magna cum laude from Brown University before receiving his MD from New York University Medical School. Though his hedge fund initially specialized in health care stocks, the firm now manages over $3.5 billion in its broader range of holdings. Industrials, utilities, financials, energy; you name it and Visium probably invests in it.
The following reviews the top more »
By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ
The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.
My last post focused on the leisure activities of baby boomers and the companies they'll patronize. While we all hope that all baby boomers get to enjoy their favorite leisure activities and travel to at least one (if not many more) of their dream destinations on their bucket list, the fact of the matter is as we age, health problems can follow.
Fortunately, there are a number of medtech more »